In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models-Reference-Cited by-同舟云学术

In Vivo Targeting of Antigens to Human Dendritic Cells Through DC-SIGN Elicits Stimulatory Immune Responses and Inhibits Tumor Growth in Grafted Mouse Models

Published:2007-10 Issue:7 Volume:30 Page:715-726
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Kretz-Rommel Anke,Qin Fenghua,Dakappagari Naveen,Torensma Ruurd,Faas Susan,Wu Dayang,Bowdish Katherine S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo;Hawiger;J Exp Med,2001

2. Dendritic cells as therapeutic vaccines against cancer;Banchereau;Nat Rev Immunol,2005

3. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization;Regnault;J Exp Med,1999

4. Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells;Kalergis;J Exp Med,2002

5. Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo;Biragyn;Blood,2004

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide‐Based Cancer Vaccine Delivery via the STINGΔTM‐cGAMP Complex;Advanced Healthcare Materials;2022-06-19

2. Achieving dendritic cell subset-specific targeting in vivo by site-directed conjugation of targeting antibodies to nanocarriers;Nano Today;2022-04

3. STxB as an Antigen Delivery Tool for Mucosal Vaccination;Toxins;2022-03-10

4. Glycan–Lectin Interactions in Cancer and Viral Infections and How to Disrupt Them;International Journal of Molecular Sciences;2021-09-30

5. Therapeutic cancer vaccine therapy for acute myeloid leukemia;Immunotherapy;2021-07